Introduction
Structural vascular changes are important in the development and maintenance of various forms of hypertension [ 11. Biochemical mechanisms underlying such structural changes, namely, the acceleration of vascular non-collagen and collagen protein synthesis secondary to hypertension, have been studied in spontaneously hypertensive rats (SHR) [2, 31 and in other experimental models of hypertension [41. However, since this acceleration of vascular protein synthesis is detected even at the very early stages in SHR, not only blood pressure itself but other factors such as genetic predisposition and neural activation of protein synthesis in vascular smooth muscle cells (SMC) also appear to contribute to the structural changes occurring in hypertension [5-71. In order to eliminate the effect of blood pressure on the vascular wall, SMC were obtained by an explant method from the aortas of SHR, stroke-prone SHR (SHRSP) [81 and Wistar-Kyoto (WKY) rats. Growth rate, the incorporation of labelled thymidine or leucine, and ornithine decarboxylase (ODC) activity, which was the ratelimiting step for polyamine biosynthesis and thus regarded as an indicator of cellular hypertrophy or hyperplasia [9, 101, were compared. 
Methods
Cultured SMC were obtained by an explant method from the thoracic aortas of age-matched 2.5-1 1 month old SHR, SHRSP and WKY rats. The media was neatly removed, dissected out as a 1 mm x Imm tissue strip and explanted in plastic culture flasks containing medium 199 supplemented with 10% foetal calf serum [ l 11. Migrated cells from these explants after 30 days of incubation were trypsinized and subcultured by repeated passages thereafter to observe growth curves. Skin fibroblasts were also cultured from neonatal rats of the three strains as a control experiment. Confluent cultured SMC of three to seven passages were used for the following experiments.
DNA and protein syntheses of these cultured SMC were observed by counting the radioactivity of SMC or protein after 12-h incubation in a medium containing [3Hlthymidine and [14Clleucine at a concentration of 0.5 pCi/mI respectively. The number of SMC was counted by a Coulter counter and protein was assayed by Lowry's method.
For measuring ODC activity [91, 10% foetal calf serum or catecholamines (2 ,ug/ml) with or without DL-propranolol (5 pg/ml) or l-methyl-3-isobutylxanthine (0.3 mmol/l) was added to the cultured SMC, which had been placed in medium 199 free of foetal calf serum for 16-18 h. At selected time intervals SMC were washed with phosphate-buffered saline and suspended in a solution containing dithiothreitol (5 mmol/l), pyridoxal phosphate (0.2 mmol/l) EDTA (4 mmol/l) and Tris/HCI (pH 7.4; 50 mmol/l). After sonication and centrifugation the supernatant fraction was assayed for the generation of I4CO, from L-[ l-14C]ornithine, which was trapped with Hyamine hydroxide and counted by a liquid scintillation spectrometer. Enzyme activity was calculated as pmol of I4CO, produced h-I of incubation mg-1 of protein at 37°C.
Results

Growth curve of cultured aortic SMC from SHR, SHRSP and W K Y rats
Cultured SMC from the aortas of SHR and SHRSP at the age of 2.5-11 months migrated faster from the explants than those from the age-matched WKY rats. Such a difference in growth rate was checked by counting the cell population for 8 days and confirmed by repeated passages as previously observed [ Effects of a-or P-agonists with or without a P-adrenoceptor blocker or phosphodiesterase inhibitor on the ODC activities of cultured aortic SMC from WK Y rats
The ODC activity of cultured SMC was clearly increased after exposure to isoprenaline and reached the maximum increase (threefold) 3 h after exposure, whereas it was only slightly elevated after exposure to noradrenaline. As shown in Fig. 1 , isoprenaline activation of ODC activity 3 h after exposure was completely blocked by the addition of the P-adrenoceptor blocker, propranolol, although propranolol itself at this dose did not affect the basal level of ODC activity.
Similarly, the phosphodiesterase inhibitor, l-methyl-3-isobutylxanthine, did not affect basal ODC activity of cultured SMC but clearly augmented isoprenaline activation of ODC activity.
Discussion
Differences in growth rate, labelled thymidine and leucine incorporation and ODC activity observed between cultured aortic SMC from SHR or SHRSP and from WKY rats suggest that vascular SMC from the rats with genetic hypertension are intrinsically (or genetically) different independently of blood pressure. However, it is still possible that aortic SMC from SHR or SHRSP even as young as 2.5 months old are already transformed into the active form due to the exposure to mild hypertension for 1 month or so, since growth rates of the cultured cells from atherosclerotic aortas were recently reported to be greater than those of control cells in rabbits fed with cholesterol for 6 months [131.
Since ODC activity was regarded as a sensitive indicator of protein synthesis [9, 101, the effect of catecholamines with or without a P-adrenoceptor blocker was observed in the present experiment, which clearly demonstrated that P-adrenoceptor stimulation activated protein synthesis of cultured vascular SMC similarly to its activation of ODC activity in myocardial cells in vivo [141. Thus we conclude that P-adrenoceptor stimulation activates vascular protein synthesis independently of blood pressure, as suggested by previous observations in vivo 1151. The augmentation of isoprenaline-induced ODC activation by a phosphodiesterase inhibitor further indicates that cyclic AMP is involved in the activation of protein synthesis by P-adrenoceptor stimulation.
These data suggest that sympathetic tone itself accelerates the structural vascular changes through the P-agonistic effects of released catecholamines from vasomotor nerve endings or from the adrenal medulla on vascular protein synthesis. Therefore, chronic treatment of hypertension by /?-blockers is theoretically beneficial, by reducing and preventing cardiovascular structural changes [151 which may finally result in cardiovascular complications in hypertension.
